Search | IOVS | ARVO Journals

View

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Lipophenols as new therapeutics toward retinal degeneration: in vitro and in vivo pharmacological studies

Esperance Moine; Nicolas Taveau; Maxime Vincent; Laurent Guillou; Sylvie Begu; Joseph Vercauteren; Thierry Durand; Celine Crauste; Philippe Brabet

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4939. doi:

ARVO Annual Meeting Abstract June 2017

A phloroglucinol-DHA derivative protects against light-induced retinal degeneration in an Abca4-deficient mouse model

Philippe Brabet; Aurélie CUBIZOLLE; Céline CRAUSTE; Laurent GUILLOU; Anne-Laure BONNEFONT; Joseph VERCAUTEREN; Thierry DURAND; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2031. doi:

ARVO Annual Meeting Abstract June 2017

A human iPSc-derived RPE model of Retinitis Punctata Albescens

Krishna Damodar; Nejla Erkilic; Laurent GUILLOU; Daria Mamaeva; Marie Pequignot; Aude Conscience; Lorenne Robert; Philippe Brabet; Christian P Hamel; Vasiliki Kalatzis

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):625. doi:

ARVO Annual Meeting Abstract June 2015

Human FATP1 overexpression in mouse retinal pigment epithelium.

Aurélie Cubizolle; laurent guillou; Claire Angebault; marie seveno; chantal cazevieille; Guy Lenaers; Philippe Brabet; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5456. doi:

ARVO Annual Meeting Abstract June 2015

Polyunsaturated Fatty Acid-Phloroglucinol conjugates protect RPE and Neural Retina against All- trans -Retinal-induced Damages

Philippe Brabet; Cubizolle Aurélie; David Cia; Celine Crauste; laurent guillou; Nathalie Jacquemot; Claire Vigor; Claire Angebault; Joseph Vercauteren; Christian P Hamel

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):29. doi:

ARVO Annual Meeting Abstract June 2013

Assessment of the therapeutic value of phloroglucinol in Stargardt’s disease

Philippe Brabet; David Cia; Claire Vigor; Nathalie Jacquemot; Benoit Lerat; Laurent Guillou; Celine Crauste; Christian Hamel; Joseph Vercauteren

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1949. doi:

ARVO Annual Meeting Abstract March 2012

Slowing Down The Visual Cycle By The Fatp1 Protein

Philippe Brabet; Laurent Guillou; Karim Chekroud

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3356. doi:

ARVO Annual Meeting Abstract April 2011

Simple And Efficient: Validation Of A Cotton Wick Electrode For Animal Electroretinography

Marie O. Pequignot; Karim Chekroud; Carl Arndt; Danièle Basset; Christian P. Hamel; Philippe Brabet

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):696. doi:

ARVO Annual Meeting Abstract April 2010

Exploration of the Visual Cycle in Fatp1-Deficient Mice

K. Chekroud; M. O. Pequignot; L. Guillou; E. Brun; C. P. Hamel; P. Brabet

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1301. doi:

ARVO Annual Meeting Abstract April 2009

Glycolytic Enzyme Modulates the Cellular Distribution and Isomerase Activity of Rpe65

P. Brabet; K. Chekroud; L. Guillou; J. Andries; M. O. Péquignot; C. P. Hamel

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3400. doi:

ARVO Annual Meeting Abstract May 2008

Reconstitution of the Human Visual Cycle Multiprotein Network in Insect Cells

P. Brabet; L. Guillou; T. J. Guignard; M. O. Péquignot; K. Chekroud; C. Joly; Y. Boublik; C. P. Hamel

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3517. doi:

ARVO Annual Meeting Abstract May 2008

Towards a Role of FATP1 in the Retinal Pigment Epithelium Visual Cycle

O. Payet; M. O. Pequignot; T. J. Guignard; L. Guillou; K. Chekroud; C. P. Hamel; P. Brabet

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3525. doi:

ARVO Annual Meeting Abstract May 2007

Spontaneous Visual Recovery After Acute Bilateral Optic Neuropathy Related to a New Opa1 Mutation in the Alternatively Spliced Exon 5b.

P. Brabet; K. Cornille; P. Amati-Bonneau; Cé. Delettre; A. Muller; D. Milea; P. Reynier; C. P. Hamel; G. Lenaers

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1667. doi:

ARVO Annual Meeting Abstract May 2006

Energetic Metabolism Proteins Interact With RPE65 in vitro

T. Guignard; A. Weber; B. Ayoub; C. Hamel; P. Brabet

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2030. doi:

Retina November 2005

Expression of the Opa1 Mitochondrial Protein in Retinal Ganglion Cells: Its Downregulation Causes Aggregation of the Mitochondrial Network

PDF

Satomi Kamei; Murielle Chen-Kuo-Chang; Chantal Cazevieille; Guy Lenaers; Aurélien Olichon; Pascale Bélenguer; Gautier Roussignol; Nicole Renard; Michel Eybalin; Adeline Michelin; Cécile Delettre; Philippe Brabet; Christian P. Hamel
TAGS: mitochondria, optic atrophy, autosomal dominant, down-regulation, mitochondrial proteins, retinal ganglion cells
Invest. Ophthalmol. Vis. Sci.. 2005; 46(11):4288-4294. doi: https://doi.org/10.1167/iovs.03-1407

ARVO Annual Meeting Abstract May 2005

Expression of Opa1 in Rat and Mouse Retina, With Emphasis on Retinal Ganglion Cells. OPA1 Down Regulation in RGCs Perturbates the Mitochondrial Function and Dynamic

G. Lenaers; M. Chen–Kuo–Chang; C. Depeyre; S. Kamei; K. Cornille; N. Renard; C. Delettre; O. Payet; C. Arndt; A. Muller; P. Brabet; C. Hamel

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3119. doi:

ARVO Annual Meeting Abstract May 2004

Search for new partners of RPE65 in retinal pigment epithelium.

P. Brabet; Y. Chassigneux; T. Guignard; C. Hamel

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1257. doi:

ARVO Annual Meeting Abstract May 2003

OPA1 Expression and Mitochondrial Distribution in the Rat Retina

S. Kamei; A. Olichon; G. Lenaers; P. Belenguer; C. Cazevieille; P. Brabet; C. Delettre; C.P. Hamel

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4574. doi:

Advertisement